News Release Details

GAITHERSBURG, Md., Feb. 20, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences in March 2015:

• Cowen and Company 35^th Annual Health Care Conference
  Boston
  March 2, 2015
  Presentation: 2:10PM Eastern
   
• Credit Suisse Under Followed Opportunities Conference 
  Boston
  March 10, 2015 
  
  
• MaidStone Life Sciences LLC 5^th Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference
  New York
  March 26, 2015

For the Cowen and Company conference, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcast will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

CONTACT: Investors Contact:
         Robert G. Burrows
         Vice President, Investor Relations
         240-631-3280
         BurrowsR@ebsi.com

         Media Contact:
         Tracey Schmitt
         Vice President, Global Public Affairs
         and Corporate Responsibility
         240-631-3200
         SchmittT@ebsi.com